Phase 3
Showing 1 - 25 of >10,000
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
Familial Chylomicronemia Syndrome Trial (VSA001 injection, Placebo)
Not yet recruiting
- Familial Chylomicronemia Syndrome
- VSA001 injection
- Placebo
- (no location specified)
Jun 9, 2023
Essential Tremor Trial (60 mg ulixacaltamide, Placebo)
Not yet recruiting
- Essential Tremor
- 60 mg ulixacaltamide
- Placebo
- (no location specified)
Oct 12, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Covid19 Trial in South Miami (Convalescent Plasma, Standard of Care)
Withdrawn
- Covid19
- Convalescent Plasma
- Standard of Care
-
South Miami, FloridaLarkin Community Hospital
Oct 12, 2023
Myopia Trial in Wenzhou (QLM3004 Concentration 1, QLM3004 Concentration 2, QLM3004 Concentration 3)
Recruiting
- Myopia
- QLM3004 Concentration 1
- +3 more
-
Wenzhou, Zhejiang, ChinaThe Affiliated Eye Hospital of Wenzhou Medical University
Nov 21, 2023
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)
Not yet recruiting
- Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
- NTLA-2001
- Placebo
- (no location specified)
Nov 8, 2023
Bowel Preparation Trial in Seoul (CTP0301-A, CTP0301-B, Cool prep)
Recruiting
- Bowel Preparation
- CTP0301-A
- +2 more
-
Seoul, Korea, Republic ofTaejoon Pharmaceutical Co., Ltd.
May 21, 2023
Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)
Not yet recruiting
- Rheumatoid Arthritis
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 25, 2023
Myocardial Infarction Trial (other, diagnostic test, device)
Not yet recruiting
- Myocardial Infarction
- Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership
- +8 more
- (no location specified)
Jun 30, 2023
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)
Not yet recruiting
- Acquired Antithrombin Deficiency
- Human plasma derived antithrombin
- Placebo
- (no location specified)
Oct 17, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Chemo-induced Peripheral Neuropathy Trial (Capsaicin, Duloxetine)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 21, 2023
Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)
Recruiting
- Cholangiocarcinoma
- Ivosidenib Oral Tablet
-
Düsseldorf, GermanyKlinik für Gastroenterologie, Hepatologie und Infektiologie Univ
May 17, 2023
Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Lenvatinib
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023
Bowel Preparation Trial in Seoul (CTP0303, Orafang Tab)
Recruiting
- Bowel Preparation
- CTP0303
- Orafang Tab
-
Seoul, Gangdong, Korea, Republic ofKyung Hee University Hospital at Gangdong
Jan 2, 2023
Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)
Recruiting
- Presbyopia
- +4 more
- Aceclidine + Brimonidine
- +2 more
-
Glendale, CaliforniaSite #101
Jan 10, 2023
Soil-Transmitted Helminthiasis (STH) Trial in Americaninhas, Accra (ZP5-9676 600 mg dose, Placebo)
Not yet recruiting
- Soil-Transmitted Helminthiasis (STH)
- ZP5-9676 600 mg dose
- Placebo
-
Americaninhas, Brazil
- +1 more
Nov 14, 2023
Gout, Hyperuricemia, Gout Flare Trial in Houston (Tigulixostat, Placebo)
Recruiting
- Gout
- +3 more
- Tigulixostat
- Placebo
-
Houston, TexasPioneer Research Solutions, Inc.
Jan 10, 2023